The Art Of Cutting Costs Without Jeopardizing Growth: An Interview With Merck Serono's Belén Garijo

Having emerged from a radical restructuring with new senior management, a revamped portfolio and a strategic ambition to morph into an oncology powerhouse on the back of its emerging markets business, CEO Belén Garijo says Merck Serono is poised to enter its growth phase.